Saturday, May 28, 2022

Hull medical technology business acquires US firm

Smith+Nephew, the Hull-founded medical technology business, has acquired Engage Surgical, owner of the only cementless unicompartmental (partial) knee system commercially available in the US.

This acquisition supports Smith+Nephew’s strategy for growth by transforming its business through innovation and acquisition, while also providing differentiation for its customers.

Randy Kilburn, Executive Vice President & General Manager, Reconstruction, Robotics and Digital, said: “Smith+Nephew is now the only medical device company offering both cemented and cementless partial knee implants in the US, as well as robotics-assistance through the CORI◊ Surgical System that is well-suited for the precise alignment needed.

“Through our Sports Medicine franchise we have an established, strong position in ASCs (Ambulatory Surgery Centres) where the vast majority of partial knees in the US are performed. Our VISIONAIRE◊ business, the high performance and small footprint of CORI, plus our partial knee portfolio, is a unique compelling offering for customers.”

The acquisition will drive Smith+Nephew’s Robotics and Real Intelligence strategy. Partial knee procedures are well-matched for robotics due to the need for precise alignment.

Engage Surgical’s Partial Knee System also complements Smith+Nephew’s focus on serving the growing outpatient market, with an increasing proportion of knee procedures performed in ASCs.

Dan Justin, Chief Executive Officer, Engage Surgical, said: “The Engage Surgical Team is excited about joining Smith+Nephew to help expand the impact of the Engage Surgical Partial Knee System and integrating it with the CORI Surgical System. Smith+Nephew is well-suited and well-prepared to continue our mission of providing better outcomes for knee arthroplasty patients.”

With Engage Surgical’s Partial Knee System, Smith+Nephew expects to be able to drive market expansion in the US, and in time in other markets as regulatory approvals are secured. Engage Surgical’s Partial Knee System currently has regulatory clearance in the US where it is in limited market release.

The partial knee market is currently worth approximately $300 million in the US (SmartTRAK) and is expected to grow faster than the total knee market and by around 4% per annum through 2029 (Millennium Research Group, Inc). Smith+Nephew expects cementless partial knees will grow ahead of overall partial knees, in line with recent patterns seen in the cementless segment.

The cost of the acquisition is up to $135 million contingent on sales performance. The acquisition was financed from existing cash and debt facilities. Engage Surgical is located in Orlando, Florida.

A message from the Editor:

Thank you for reading this story on our news site - please take a moment to read this important message:

As you know, our aim is to bring you, the reader, an editorially led news site and magazine but journalism costs money and we rely on advertising, print and digital revenues to help to support them.

With the Covid-19 pandemichaving a major impact on our industry as a whole, the advertising revenues we normally receive, which helps us cover the cost of our journalists and this website, have been drastically affected.

As such we need your help. If you can support our news sites/magazines with either a small donation of even £1, or a subscription to our magazine, which costs just £31.50 per year, (inc p&P and mailed direct to your door) your generosity will help us weather the storm and continue in our quest to deliver quality journalism.

As a subscriber, you will have unlimited access to our web site and magazine. You'll also be offered VIP invitations to our events, preferential rates to all our awards and get access to exclusive newsletters and content.

Just click here to subscribe and in the meantime may I wish you the very best.

Latest news

Related news

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.